Canada (CA)

Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma (2018) Ohe C, Smith SC, Sirohi D, Divatia M, De Peralta-Venturina M, Paner GP, Agaimy A, et al. Journal article Projections for the changes in growing season length of tree-ring formation on the Tibetan Plateau based on CMIP5 model simulations (2018) He M, Yang B, Shishov V, Rossi S, Bräuning A, Ljungqvist FC, Grießinger J Journal article, Original article Tree rings reveal globally coherent signature of cosmogenic radiocarbon events in 774 and 993 CE (2018) Buntgen U, Wacker L, Galvan JD, Arnold S, Arseneault D, Baillie M, Beer J, et al. Journal article, Original article Relationships betweenwood formation and cambium phenology on the Tibetan plateau during 1960-2014 (2018) He M, Yang B, Shishov V, Rossi S, Bräuning A, Ljungqvist FC, Grießinger J Journal article, Original article Projections for the changes in growing season length of tree-ring formation on the Tibetan Plateau based on CMIP5 model simulations (2018) He M, Yang B, Shishov V, Rossi S, Bräuning A, Ljungqvist FC, Grießinger J Journal article, Original article Erratum to: Tree rings reveal globally coherent signature of cosmogenic radiocarbon events in 774 and 993 CE (Nature Communications, (2018), 9, 1, (3605), 10.1038/s41467-018-06036-0) (2018) Buntgen U, Wacker L, Galvan JD, Arnold S, Arseneault D, Baillie M, Beer J, et al. Journal article, Erratum Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations (2018) Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, et al. Journal article DNA methylation-based classification of central nervous system tumours (2018) Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, et al. Journal article Joint Repair While Initiating Biologic Therapy in Rheumatoid Arthritis (2018) Brunet S, Manske S, Engelke K, Boyd SK, Barnabe C Conference contribution Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial (2018) Hurvitz SA, Martin M, Symmans WF, Jung KH, Huang CS, Thompson AM, Harbeck N, et al. Journal article